Developer docs
API playgroundTry for free, no card

Search company profiles

Metastatic Breast Cancer Network

Full company profile

uuid002feri

Namestring
Metastatic Breast Cancer Network
Legal namestring
Metastatic Breast Cancer Network
Websiteurl
mbcn.org
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Metastatic Breast Cancer Network (MBCN) is a volunteer, patient-led 501(c)(3) nonprofit advocacy organization founded in 2004 and headquartered in New York (c/o SHARE, 165 West 46th St., Suite 712). It is the first organization solely devoted to the needs of patients with metastatic (Stage IV) breast cancer, serving an estimated 155,000 U.S. individuals living with MBC along with their caregivers and families. MBCN's mission centers on reducing isolation, providing disease-specific education, advocating for research funding, and amplifying the patient voice in policy and clinical trial design.

The organization delivers a portfolio of free patient resources: the MBC Connect mobile and web-based interactive patient registry and research portal (HIPAA-compliant, English/Spanish); the Metastatic Trial Search clinical trial finder powered by BreastCancerTrials.org; downloadable educational brochures; a peer-support telephone hotline and telephone support groups; online message boards; an e-newsletter; and patient-advocacy toolkits. MBC Connect enables patients to maintain longitudinal treatment profiles, complete quality-of-life surveys, and receive personalized news and clinical trial matches, building a de-identified dataset that supports MBC research. The organization also organizes and sponsors regional conferences and webinars.

MBCN operates on a donation- and sponsorship-based revenue model with no fees charged to patients or caregivers. Funding sources include individual and memorial donations, corporate sponsorships from pharmaceutical companies (notably Novartis's Kiss This 4 MBC campaign) and grants. Strategic alliances are central to its model: MBCN is a core member of the Metastatic Breast Cancer Alliance (32 nonprofits, 11 pharma/biotech firms, 18 patient advocates), collaborates with academic centers (UNC Lineberger, University of Pittsburgh Cancer Institute), Komen affiliates, METAvivor, and BreastCancerTrials.org, and played a leading role in establishing October 13 as National Metastatic Breast Cancer Awareness Day via U.S. Congressional resolutions in 2009.

Short descriptiontext

Metastatic Breast Cancer Network is a volunteer, patient-led 501(c)(3) nonprofit founded in 2004 that provides free education, peer support, clinical trial navigation, and the MBC Connect patient registry for the estimated 155,000 U.S. individuals living with Stage IV breast cancer and their caregivers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
metastatic breast cancer support, patient advocacy services, cancer clinical trials, peer support programs, patient education resources
Industry1 code
1Rare Disease & Special Needs Support Organizations
CodeBPAGACAMPrimaryYes
NAICS code4 codes
  • Social Advocacy Organizations8133
  • Voluntary Health Organizations813212
  • Other Individual and Family Services624190
  • Individual and Family Services6241
SIC code3 codes
  • Services-Social Services8300
  • Services-Health Services8000
  • Services-Membership Organizations8600
Product category
Nonprofit Patient Advocacy Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Donations and Memorial Contributions
TypeOthers
Description

MBCN receives contributions made in memory of patients whose lives were cut short by metastatic breast cancer to fund research leadership awards and operational activities.

mbcn.org
2Corporate Sponsorships
TypeAffiliate Referral
Description

Partnerships with pharmaceutical companies like Novartis for campaigns such as Kiss This 4 MBC generate donations to fund metastatic breast cancer research.

mbcn.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Operations, Others
Pricing details1 tier
1Free patient resources and tools
ModelFreemiumBilling cadenceOthers
Notes

All educational materials, brochures, clinical trial finder tool, and MBC Connect registry are provided free of charge. Available in English and Spanish.

mbcn.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

MBCN is a volunteer, patient-led advocacy organization that provides free information, education, peer support, and digital tools for people living with metastatic (Stage IV) breast cancer and their caregivers. Core offerings include the MBC Connect interactive patient registry, the Metastatic Trial Search clinical trial finder, free downloadable educational brochures, peer support hotlines and telephone support groups, online communities, advocacy resources, and sponsored educational conferences.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • MBC Connect provides patients opportunity to own and update their own health information while analyzing aggregated patient data
+1 more record
Product overview1 text field

Metastatic Breast Cancer Network (MBCN) is a volunteer, patient-led advocacy organization that provides information, resources, and support for people living with metastatic (Stage IV) breast cancer. The organization operates primarily as an information and support hub rather than a technology company. Its core offerings include MBC Connect, an interactive patient registry and research tool; the Metastatic Trial Search clinical trial finder; free educational brochures; peer support via telephone hotline and support groups; online communities; and patient advocacy resources. MBCN also organizes and sponsors conferences and educational events, and champions clinical trials and research funding for metastatic breast cancer.

Product and service4 records
1MBC Connect
CategoryPatient registry and research portal
2Metastatic Trial Search
CategoryClinical trial matching
3Clinical Trials Finder
CategoryClinical trial matching
4Free Brochures
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1Metastatic Breast Cancer Alliance
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-10-13
Description

MBC Alliance is a consortium of 32 nonprofit organizations, 11 pharmaceutical/biotech companies, and 18 individual patient advocates. MBCN participates in the alliance which works to transform and improve lives of people living with MBC through advancing research, improving patient knowledge, and increasing public understanding of MBC. MBC Connect was launched by the Alliance.

mbcn.org
2Metastatic Breast Cancer Connect Registry
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2018-10-13
Description

Interactive patient registry and research portal that provides patients ability to update information over time, respond to surveys about their MBC history and quality of life, and receive personalized clinical trial opportunities. Data is de-identified, encrypted, and HIPAA-compliant.

mbcn.org
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2018-09-28
Description

MBCN partnered with UNC Lineberger researchers for a national survey of 1,054 women with metastatic breast cancer on financial toxicity. MBCN helped recruit participants and offered a $10 Amazon gift card for survey completion.

Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2017-10-27
Description

MBCN partnered with Susan G. Komen Greater NYC as an association partner for the Truth and Dare Metastatic Breast Cancer Conference, providing learning, fellowship, and current information on MBC treatments and research.

Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2017-09-22
Description

MBCN participated as a sponsor and partner in the Northwest Metastatic Breast Cancer Conference supported by Komen Puget Sound, Amazon Web Services, Swedish Cancer Institute, and other sponsors.

Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2017-09-14
Description

Novartis partnered with MBCN and METAvivor for the Kiss This 4 MBC campaign. For every social media post using #KissThis4MBC, Novartis donated $10 to MBCN and METAvivor, with a goal of generating at least $200,000 for metastatic breast cancer research.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2017-09-14
Description

MBCN partners with METAvivor for advocacy campaigns including Kiss This 4 MBC. Both are patient-driven advocacy organizations dedicated to supporting research for people living with metastatic breast cancer.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2017-03-08
Description

MBCN awarded Dr. Steffi Oesterreich a $100,000 Research Leadership Award to support her research on invasive lobular breast cancer as a distinct subtype of metastatic breast cancer.

Strategic tierCoreTypeTechnology or Integration
Description

Metastatic Breast Cancer Alliance partnered with BreastCancerTrials.org to create the Metastatic Trial Search engine that translates clinical trial descriptions into plain English for easier patient access.

Strategic tierMinorTypeOthers
Description

MBCN is hosted at SHARE's New York office location. SHARE is a cancer support organization providing resources for breast and ovarian cancer patients.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest U.S. cancer nonprofit providing research funding, patient support, and education across all cancer types, including a dedicated MBC program. Overlaps with MBCN in patient education and research funding but operates at vastly larger scale across all cancers.

TypeDirect peer
Description

Cancer support organization for breast and ovarian cancer patients that hosts MBCN at its New York office. Provides peer support, helplines, and educational programs that closely mirror MBCN's offerings and patient segments.

TypeDirect peer
Description

Major nonprofit providing medically reviewed breast cancer information, community forums, and clinical trial resources. Highly comparable as a free digital education and peer community destination for breast cancer patients, including those with metastatic disease.

TypeBroad incumbent
Description

Largest U.S. breast cancer nonprofit, with significant MBC programming and regional affiliates (e.g., Komen Greater NYC, Komen Puget Sound) that partner with MBCN. Operates in the same patient space but with vastly greater fundraising, marketing, and grantmaking scale.

TypeDirect peer
Description

Nonprofit supporting young adults diagnosed with breast cancer through resources, advocacy, and community. Comparable as a peer-support and education nonprofit targeting a defined breast cancer sub-population, though focused on age rather than stage.

TypeDirect peer
Description

Breast cancer advocacy organization focused on young women, with strong emphasis on MBC patients of color and patient-led programs. Comparable as a younger, patient-led advocacy nonprofit with similar education, support, and policy missions.

TypeDirect peer
Description

Patient-driven metastatic breast cancer advocacy nonprofit that funds research grants and runs MBC awareness campaigns. METAvivor is the most directly comparable peer — co-partner with MBCN on Kiss This 4 MBC and shares the same mission, donor base, and patient-led model.

TypeDirect peer
Description

Advocacy-focused breast cancer nonprofit that lobbies for research funding and policy change. Comparable to MBCN as a policy-driven advocacy voice for breast cancer patients, though broader in scope.

TypeDirect peer
Description

National nonprofit providing education and support to people affected by breast cancer, including a dedicated metastatic program. Comparable as a peer-led education and support organization with overlapping patient resources, conferences, and helpline services.

10Metastatic Breast Cancer Alliance
TypeOthers
Description

Coalition of 60+ nonprofits, pharma companies, and patient advocates — of which MBCN is a founding member — that coordinates cross-organization MBC research and advocacy. Treated as an ecosystem/parent-like entity rather than a direct competitor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Metastatic Breast Cancer Network

Nonprofit Patient Advocacy Servicesmbcn.org

Metastatic Breast Cancer Network is a volunteer, patient-led 501(c)(3) nonprofit founded in 2004 that provides free education, peer support, clinical trial navigation, and the MBC Connect patient registry for the estimated 155,000 U.S. individuals living with Stage IV breast cancer and their caregivers.

What Metastatic Breast Cancer Network does

Metastatic Breast Cancer Network (MBCN) is a volunteer, patient-led 501(c)(3) nonprofit advocacy organization founded in 2004 and headquartered in New York (c/o SHARE, 165 West 46th St., Suite 712). It is the first organization solely devoted to the needs of patients with metastatic (Stage IV) breast cancer, serving an estimated 155,000 U.S. individuals living with MBC along with their caregivers and families. MBCN's mission centers on reducing isolation, providing disease-specific education, advocating for research funding, and amplifying the patient voice in policy and clinical trial design.

The organization delivers a portfolio of free patient resources: the MBC Connect mobile and web-based interactive patient registry and research portal (HIPAA-compliant, English/Spanish); the Metastatic Trial Search clinical trial finder powered by BreastCancerTrials.org; downloadable educational brochures; a peer-support telephone hotline and telephone support groups; online message boards; an e-newsletter; and patient-advocacy toolkits. MBC Connect enables patients to maintain longitudinal treatment profiles, complete quality-of-life surveys, and receive personalized news and clinical trial matches, building a de-identified dataset that supports MBC research. The organization also organizes and sponsors regional conferences and webinars.

MBCN operates on a donation- and sponsorship-based revenue model with no fees charged to patients or caregivers. Funding sources include individual and memorial donations, corporate sponsorships from pharmaceutical companies (notably Novartis's Kiss This 4 MBC campaign) and grants. Strategic alliances are central to its model: MBCN is a core member of the Metastatic Breast Cancer Alliance (32 nonprofits, 11 pharma/biotech firms, 18 patient advocates), collaborates with academic centers (UNC Lineberger, University of Pittsburgh Cancer Institute), Komen affiliates, METAvivor, and BreastCancerTrials.org, and played a leading role in establishing October 13 as National Metastatic Breast Cancer Awareness Day via U.S. Congressional resolutions in 2009.

Metastatic Breast Cancer Network firmographics

Firmographics
Name
Metastatic Breast Cancer Network
Legal name
Metastatic Breast Cancer Network
Website
https://mbcn.org
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
1–10 employees
Short description
Metastatic Breast Cancer Network is a volunteer, patient-led 501(c)(3) nonprofit founded in 2004 that provides free education, peer support, clinical trial navigation, and the MBC Connect patient registry for the estimated 155,000 U.S. individuals living with Stage IV breast cancer and their caregivers.
Ownership category
akta.pro rank

Metastatic Breast Cancer Network industry classification

Industry
Product category
Nonprofit Patient Advocacy Services
NAICS
Social Advocacy Organizations (8133), Voluntary Health Organizations (813212), Other Individual and Family Services (624190), Individual and Family Services (6241)
SIC
Services-Social Services (8300), Services-Health Services (8000), Services-Membership Organizations (8600)
akta.pro primary industry
Rare Disease & Special Needs Support Organizations (BPAGACAM)

Keywords

  • Metastatic breast cancer support
  • Patient advocacy services
  • Cancer clinical trials
  • Peer support programs
  • Patient education resources

Where Metastatic Breast Cancer Network is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Metastatic Breast Cancer Network business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Others

Revenue model

  1. Donations and Memorial Contributions: MBCN receives contributions made in memory of patients whose lives were cut short by metastatic breast cancer to fund research leadership awards and operational activities.
  2. Corporate Sponsorships: Partnerships with pharmaceutical companies like Novartis for campaigns such as Kiss This 4 MBC generate donations to fund metastatic breast cancer research.

Pricing tiers

ModelBillingPrice
FreemiumOthersFree patient resources and tools

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Metastatic Breast Cancer Network product offering

Product offering

Core offering

MBCN is a volunteer, patient-led advocacy organization that provides free information, education, peer support, and digital tools for people living with metastatic (Stage IV) breast cancer and their caregivers. Core offerings include the MBC Connect interactive patient registry, the Metastatic Trial Search clinical trial finder, free downloadable educational brochures, peer support hotlines and telephone support groups, online communities, advocacy resources, and sponsored educational conferences.

Product overview

Metastatic Breast Cancer Network (MBCN) is a volunteer, patient-led advocacy organization that provides information, resources, and support for people living with metastatic (Stage IV) breast cancer. The organization operates primarily as an information and support hub rather than a technology company. Its core offerings include MBC Connect, an interactive patient registry and research tool; the Metastatic Trial Search clinical trial finder; free educational brochures; peer support via telephone hotline and support groups; online communities; and patient advocacy resources. MBCN also organizes and sponsors conferences and educational events, and champions clinical trials and research funding for metastatic breast cancer.

Differentiator

Problem solved

Functional benefit

Products and services

  • MBC Connect
  • Metastatic Trial Search
  • Clinical Trials Finder
  • Free Brochures

Quantifiable outcome

  • MBC Connect provides patients opportunity to own and update their own health information while analyzing aggregated patient data
  • +1 more outcomes

Companies that use Metastatic Breast Cancer Network

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles1 record

Metastatic Breast Cancer Network technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Metastatic Breast Cancer Network partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, major and minor.

  • Metastatic Breast Cancer AlliancecoreStrategic or Co-development Partner · 13 October 2018MBC Alliance is a consortium of 32 nonprofit organizations, 11 pharmaceutical/biotech companies, and 18 individual patient advocates. MBCN participates in the alliance which works to transform and improve lives of people living with MBC through advancing research, improving patient knowledge, and increasing public understanding of MBC. MBC Connect was launched by the Alliance.
  • Metastatic Breast Cancer Connect RegistrycoreTechnology or Integration · 13 October 2018Interactive patient registry and research portal that provides patients ability to update information over time, respond to surveys about their MBC history and quality of life, and receive personalized clinical trial opportunities. Data is de-identified, encrypted, and HIPAA-compliant.
  • University of North Carolina Lineberger Comprehensive Cancer CentermajorStrategic or Co-development Partner · 28 September 2018MBCN partnered with UNC Lineberger researchers for a national survey of 1,054 women with metastatic breast cancer on financial toxicity. MBCN helped recruit participants and offered a $10 Amazon gift card for survey completion.
  • Susan G. Komen Greater NYCmajorGTM or Marketing Partner · 27 October 2017MBCN partnered with Susan G. Komen Greater NYC as an association partner for the Truth and Dare Metastatic Breast Cancer Conference, providing learning, fellowship, and current information on MBC treatments and research.
  • Susan G. Komen Puget SoundmajorGTM or Marketing Partner · 22 September 2017MBCN participated as a sponsor and partner in the Northwest Metastatic Breast Cancer Conference supported by Komen Puget Sound, Amazon Web Services, Swedish Cancer Institute, and other sponsors.
  • NovartismajorGTM or Marketing Partner · 14 September 2017Novartis partnered with MBCN and METAvivor for the Kiss This 4 MBC campaign. For every social media post using #KissThis4MBC, Novartis donated $10 to MBCN and METAvivor, with a goal of generating at least $200,000 for metastatic breast cancer research.
  • METAvivormajorStrategic or Co-development Partner · 14 September 2017MBCN partners with METAvivor for advocacy campaigns including Kiss This 4 MBC. Both are patient-driven advocacy organizations dedicated to supporting research for people living with metastatic breast cancer.
  • University of Pittsburgh Cancer InstitutemajorStrategic or Co-development Partner · 8 March 2017MBCN awarded Dr. Steffi Oesterreich a $100,000 Research Leadership Award to support her research on invasive lobular breast cancer as a distinct subtype of metastatic breast cancer.
  • BreastCancerTrials.orgcoreTechnology or IntegrationMetastatic Breast Cancer Alliance partnered with BreastCancerTrials.org to create the Metastatic Trial Search engine that translates clinical trial descriptions into plain English for easier patient access.
  • SHARE Cancer SupportminorOthersMBCN is hosted at SHARE's New York office location. SHARE is a cancer support organization providing resources for breast and ovarian cancer patients.

Scale indicators5 records

Recent moves6 records

Expansion highlights3 records

Metastatic Breast Cancer Network competitors and assessment

Company assessment

Broad incumbents

  • American Cancer Society: Largest U.S. cancer nonprofit providing research funding, patient support, and education across all cancer types, including a dedicated MBC program. Overlaps with MBCN in patient education and research funding but operates at vastly larger scale across all cancers.
  • Susan G. Komen: Largest U.S. breast cancer nonprofit, with significant MBC programming and regional affiliates (e.g., Komen Greater NYC, Komen Puget Sound) that partner with MBCN. Operates in the same patient space but with vastly greater fundraising, marketing, and grantmaking scale.

Direct peers

  • SHARE Cancer Support: Cancer support organization for breast and ovarian cancer patients that hosts MBCN at its New York office. Provides peer support, helplines, and educational programs that closely mirror MBCN's offerings and patient segments.
  • Breastcancer.org: Major nonprofit providing medically reviewed breast cancer information, community forums, and clinical trial resources. Highly comparable as a free digital education and peer community destination for breast cancer patients, including those with metastatic disease.
  • Young Survival Coalition (YSC): Nonprofit supporting young adults diagnosed with breast cancer through resources, advocacy, and community. Comparable as a peer-support and education nonprofit targeting a defined breast cancer sub-population, though focused on age rather than stage.
  • Tigerlily Foundation: Breast cancer advocacy organization focused on young women, with strong emphasis on MBC patients of color and patient-led programs. Comparable as a younger, patient-led advocacy nonprofit with similar education, support, and policy missions.
  • METAvivor: Patient-driven metastatic breast cancer advocacy nonprofit that funds research grants and runs MBC awareness campaigns. METAvivor is the most directly comparable peer — co-partner with MBCN on Kiss This 4 MBC and shares the same mission, donor base, and patient-led model.
  • National Breast Cancer Coalition (NBCC): Advocacy-focused breast cancer nonprofit that lobbies for research funding and policy change. Comparable to MBCN as a policy-driven advocacy voice for breast cancer patients, though broader in scope.
  • Living Beyond Breast Cancer (LBBC): National nonprofit providing education and support to people affected by breast cancer, including a dedicated metastatic program. Comparable as a peer-led education and support organization with overlapping patient resources, conferences, and helpline services.

Others

  • Metastatic Breast Cancer Alliance: Coalition of 60+ nonprofits, pharma companies, and patient advocates — of which MBCN is a founding member — that coordinates cross-organization MBC research and advocacy. Treated as an ecosystem/parent-like entity rather than a direct competitor.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Metastatic Breast Cancer Network social profiles

Digital presence

Metastatic Breast Cancer Network financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Metastatic Breast Cancer Network leadership team

Management profile

Number of profiles

Profiles3 records

Metastatic Breast Cancer Network funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Metastatic Breast Cancer Network M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metastatic Breast Cancer Network

What does Metastatic Breast Cancer Network do?

MBCN is a volunteer, patient-led advocacy organization that provides free information, education, peer support, and digital tools for people living with metastatic (Stage IV) breast cancer and their caregivers. Core offerings include the MBC Connect interactive patient registry, the Metastatic Trial Search clinical trial finder, free downloadable educational brochures, peer support hotlines and telephone support groups, online communities, advocacy resources, and sponsored educational conferences.

Is Metastatic Breast Cancer Network a public or private company?

Metastatic Breast Cancer Network is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Metastatic Breast Cancer Network founded?

Metastatic Breast Cancer Network was founded in 2004. It employs 1 to 10 people.

Where is Metastatic Breast Cancer Network based?

Metastatic Breast Cancer Network is headquartered in New York, United States, in the North America region.

How does Metastatic Breast Cancer Network make money?

Two revenue lines are on record. Donations and Memorial Contributions are the primary driver. The others are corporate Sponsorships.

Who are Metastatic Breast Cancer Network's main competitors?

Broad incumbents on record are American Cancer Society and Susan G. Komen. Direct peers are SHARE Cancer Support, Breastcancer.org, Young Survival Coalition (YSC), Tigerlily Foundation, METAvivor, National Breast Cancer Coalition (NBCC) and Living Beyond Breast Cancer (LBBC). Metastatic Breast Cancer Alliance is listed as an others.

Does Metastatic Breast Cancer Network have an API?

No public API is recorded for Metastatic Breast Cancer Network.

What industry is Metastatic Breast Cancer Network in?

Metastatic Breast Cancer Network's product category is Nonprofit Patient Advocacy Services. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations. Its NAICS code is 8133 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAward-Winning Television Host Meredith Vieira Joins Pfizer's Find Your MBC Voice to Help Empower People Living with Metastatic Breast Cancer to Speak UpPfizer Inc. has launched "Find Your MBC Voice," an initiative aimed at empowering people living with metastatic breast cancer to take active roles in their treatment decisions, with television host Meredith Vieira joining as a celebrity advocate alongside five leading breast cancer patient advocacy organizations. The initiative provides a Treatment Discussion Guide and includes WMBC Radio, a streaming radio station with twelve episodes featuring advocates and healthcare professionals discussing metastatic breast cancer management. A 2014 Pfizer study found that conversations in oncologists' offices were largely doctor-driven, with only half of metastatic breast cancer patients believing they had a voice in their treatment options.PR NewswireMetastatic Breast Cancer Alliance Announces Release of MBC Connect 2.0The Metastatic Breast Cancer Alliance (MBCA) announced the release of MBC Connect 2.0, a patient experience registry designed to help metastatic breast cancer patients find clinical trials. This new version simplifies the trial search process and offers personalized trial matching to enhance patient participation in clinical research. MBC Connect 2.0 aims to increase accessibility and promote better treatment options for patients by aligning them with researchers.GlobeNewswireLiving Beyond Breast Cancer and Metastatic Breast Cancer Network Release New PublicationLiving Beyond Breast Cancer and the Metastatic Breast Cancer Network released a free guide for newly diagnosed stage IV breast cancer patients. The guide covers medical, emotional, and practical concerns and is available for free online or by phone. It aims to help women understand tests, treatments, and emotional well-being.